Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients

Clinical trial NCT05352347 · UNKNOWN

Trial details

NCT number: NCT05352347
Sponsor: Shaperon
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2022-04-12
Primary completion: 2024-11-30
Enrollment: 1134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.